Effectiveness of Sulfadoxine–Pyrimethamine for Intermittent Preventive Treatment of Malaria and Adverse Birth Outcomes in Pregnant Women

Gelijkaardige items

• Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania
  door: Witness Mkalukwatage Mchwampaka, et al.
  Gepubliceerd in: (2019-11-01)
• Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance
  door: Sesh A. Sundararaman, et al.
  Gepubliceerd in: (2022-08-01)
• Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon
  door: Judith K. Anchang-Kimbi, et al.
  Gepubliceerd in: (2020-03-01)
• Risk factors for placental malaria, sulfadoxine-pyrimethamine doses, and birth outcomes in a rural to urban prospective cohort study on the Bandiagara Escarpment and Bamako, Mali
  door: Claudius Vincenz, et al.
  Gepubliceerd in: (2022-03-01)
• Intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana
  door: Atikatou Mama, et al.
  Gepubliceerd in: (2022-03-01)